Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a special liquid help dental implants take root better?

NCT ID NCT07627633

Disease control Sponsor: Ain Shams University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether adding a liquid called Theravex to a bone graft helps people with low bone in the upper jaw get stronger dental implants. Sixteen adults will receive either the standard bone graft or a graft mixed with Theravex during a sinus lift procedure. The main goal is to see if the mixture improves bone growth and implant stability over three to six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Theravex (Bone Bioactive Liquid) mixed with equine granulate xenograft
What this could lead to
If it works, this could lead to a better way to grow bone in the sinus area, making dental implants more stable and successful.
What could go wrong
This is a very small early study with only 16 people, so results may not apply to everyone. The treatment is for a specific dental procedure, not a general health breakthrough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 16 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

May 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient partially edentulous with maxillary posterior edentulous ridge after extraction of more than 4 months. * Both genders will be selected males and females. * Adult patients aged between 21 and 50 years of age. * Good general health (American Society of Anesthesiology Physical Status I-II). * Initial residual alveolar ridge height ranging between 4 to 6 mm according to preoperative CBCT. * No previous surgery or radiation treatment on the maxillary sinus Exclusion Criteria: * Smokers * Pregnant and lactating females. * Poor oral hygiene (Full-Mouth Plaque Score (FMPS) \> 20%). * Patients with occlusal or malalignment problems. * Patients with parafunctional habits. * Presence of acute or chronic sinus pathoses or sinus membrane perforation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Internal sinus lifting are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Internal sinus lifting

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Faculty of Dentistry Ain Shams university

    Cairo, 11566, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.